nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—RARA—amyotrophic lateral sclerosis	0.55	1	CbGaD
Tretinoin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.196	1	CbGbCtD
Tretinoin—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0235	CcSEcCtD
Tretinoin—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0229	CcSEcCtD
Tretinoin—CRABP1—hindbrain—amyotrophic lateral sclerosis	0.00264	0.0557	CbGeAlD
Tretinoin—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0204	CcSEcCtD
Tretinoin—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0204	CcSEcCtD
Tretinoin—RARG—tongue—amyotrophic lateral sclerosis	0.00228	0.0479	CbGeAlD
Tretinoin—Isotretinoin—RARA—amyotrophic lateral sclerosis	0.00221	0.375	CrCbGaD
Tretinoin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0177	CcSEcCtD
Tretinoin—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0177	CcSEcCtD
Tretinoin—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0177	CcSEcCtD
Tretinoin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0171	CcSEcCtD
Tretinoin—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0168	CcSEcCtD
Tretinoin—ALDH1A1—hindbrain—amyotrophic lateral sclerosis	0.00199	0.042	CbGeAlD
Tretinoin—Acitretin—RARA—amyotrophic lateral sclerosis	0.00188	0.319	CrCbGaD
Tretinoin—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0153	CcSEcCtD
Tretinoin—Alitretinoin—RARA—amyotrophic lateral sclerosis	0.0018	0.306	CrCbGaD
Tretinoin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0146	CcSEcCtD
Tretinoin—ALDH1A2—embryo—amyotrophic lateral sclerosis	0.00171	0.0361	CbGeAlD
Tretinoin—CRABP1—embryo—amyotrophic lateral sclerosis	0.00165	0.0348	CbGeAlD
Tretinoin—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0132	CcSEcCtD
Tretinoin—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.013	CcSEcCtD
Tretinoin—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.013	CcSEcCtD
Tretinoin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0128	CcSEcCtD
Tretinoin—CRABP1—brainstem—amyotrophic lateral sclerosis	0.00152	0.0319	CbGeAlD
Tretinoin—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0124	CcSEcCtD
Tretinoin—CRABP2—embryo—amyotrophic lateral sclerosis	0.0015	0.0315	CbGeAlD
Tretinoin—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0118	CcSEcCtD
Tretinoin—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0115	CcSEcCtD
Tretinoin—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0115	CcSEcCtD
Tretinoin—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0113	CcSEcCtD
Tretinoin—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0111	CcSEcCtD
Tretinoin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0107	CcSEcCtD
Tretinoin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0106	CcSEcCtD
Tretinoin—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0105	CcSEcCtD
Tretinoin—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0103	CcSEcCtD
Tretinoin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0103	CcSEcCtD
Tretinoin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0103	CcSEcCtD
Tretinoin—ALDH1A1—embryo—amyotrophic lateral sclerosis	0.00125	0.0262	CbGeAlD
Tretinoin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00951	CcSEcCtD
Tretinoin—ALDH1A1—brainstem—amyotrophic lateral sclerosis	0.00114	0.0241	CbGeAlD
Tretinoin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00935	CcSEcCtD
Tretinoin—CRABP1—medulla oblongata—amyotrophic lateral sclerosis	0.00106	0.0223	CbGeAlD
Tretinoin—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.000984	0.00812	CcSEcCtD
Tretinoin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00801	CcSEcCtD
Tretinoin—CRABP2—medulla oblongata—amyotrophic lateral sclerosis	0.000956	0.0201	CbGeAlD
Tretinoin—Gout—Riluzole—amyotrophic lateral sclerosis	0.000946	0.0078	CcSEcCtD
Tretinoin—CRABP1—spinal cord—amyotrophic lateral sclerosis	0.000943	0.0198	CbGeAlD
Tretinoin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000939	0.00775	CcSEcCtD
Tretinoin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000933	0.0077	CcSEcCtD
Tretinoin—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.000933	0.0077	CcSEcCtD
Tretinoin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000933	0.0077	CcSEcCtD
Tretinoin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.000933	0.0077	CcSEcCtD
Tretinoin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.000927	0.00765	CcSEcCtD
Tretinoin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000905	0.00746	CcSEcCtD
Tretinoin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00741	CcSEcCtD
Tretinoin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.000894	0.00737	CcSEcCtD
Tretinoin—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00728	CcSEcCtD
Tretinoin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00728	CcSEcCtD
Tretinoin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00724	CcSEcCtD
Tretinoin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000872	0.0072	CcSEcCtD
Tretinoin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00703	CcSEcCtD
Tretinoin—CRABP2—spinal cord—amyotrophic lateral sclerosis	0.000852	0.0179	CbGeAlD
Tretinoin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00695	CcSEcCtD
Tretinoin—RXRG—medulla oblongata—amyotrophic lateral sclerosis	0.000836	0.0176	CbGeAlD
Tretinoin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00684	CcSEcCtD
Tretinoin—ALDH1A2—nervous system—amyotrophic lateral sclerosis	0.000823	0.0173	CbGeAlD
Tretinoin—RARRES1—brain—amyotrophic lateral sclerosis	0.00082	0.0173	CbGeAlD
Tretinoin—Coma—Riluzole—amyotrophic lateral sclerosis	0.000807	0.00665	CcSEcCtD
Tretinoin—ALDH1A1—medulla oblongata—amyotrophic lateral sclerosis	0.000796	0.0168	CbGeAlD
Tretinoin—CRABP1—nervous system—amyotrophic lateral sclerosis	0.000794	0.0167	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—amyotrophic lateral sclerosis	0.000793	0.0167	CbGeAlD
Tretinoin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00648	CcSEcCtD
Tretinoin—ALDH1A2—cerebellum—amyotrophic lateral sclerosis	0.000775	0.0163	CbGeAlD
Tretinoin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000766	0.00632	CcSEcCtD
Tretinoin—CRABP1—central nervous system—amyotrophic lateral sclerosis	0.000765	0.0161	CbGeAlD
Tretinoin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00626	CcSEcCtD
Tretinoin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00619	CcSEcCtD
Tretinoin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00619	CcSEcCtD
Tretinoin—CRABP1—cerebellum—amyotrophic lateral sclerosis	0.000747	0.0157	CbGeAlD
Tretinoin—RXRG—spinal cord—amyotrophic lateral sclerosis	0.000745	0.0157	CbGeAlD
Tretinoin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00613	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00608	CcSEcCtD
Tretinoin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00608	CcSEcCtD
Tretinoin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00602	CcSEcCtD
Tretinoin—CRABP2—nervous system—amyotrophic lateral sclerosis	0.000718	0.0151	CbGeAlD
Tretinoin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00591	CcSEcCtD
Tretinoin—RXRA—nervous system—amyotrophic lateral sclerosis	0.000715	0.0151	CbGeAlD
Tretinoin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000713	0.00588	CcSEcCtD
Tretinoin—ALDH1A1—spinal cord—amyotrophic lateral sclerosis	0.00071	0.015	CbGeAlD
Tretinoin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00583	CcSEcCtD
Tretinoin—NR0B1—brain—amyotrophic lateral sclerosis	0.000706	0.0149	CbGeAlD
Tretinoin—CRABP2—central nervous system—amyotrophic lateral sclerosis	0.000691	0.0146	CbGeAlD
Tretinoin—RXRA—central nervous system—amyotrophic lateral sclerosis	0.000688	0.0145	CbGeAlD
Tretinoin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000679	0.0056	CcSEcCtD
Tretinoin—CRABP2—cerebellum—amyotrophic lateral sclerosis	0.000676	0.0142	CbGeAlD
Tretinoin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00544	CcSEcCtD
Tretinoin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00542	CcSEcCtD
Tretinoin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00529	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00529	CcSEcCtD
Tretinoin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000631	0.0052	CcSEcCtD
Tretinoin—ALDH1A2—brain—amyotrophic lateral sclerosis	0.000629	0.0132	CbGeAlD
Tretinoin—RXRG—nervous system—amyotrophic lateral sclerosis	0.000628	0.0132	CbGeAlD
Tretinoin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00516	CcSEcCtD
Tretinoin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000619	0.0051	CcSEcCtD
Tretinoin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00503	CcSEcCtD
Tretinoin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00501	CcSEcCtD
Tretinoin—CRABP1—brain—amyotrophic lateral sclerosis	0.000607	0.0128	CbGeAlD
Tretinoin—RARB—cerebellum—amyotrophic lateral sclerosis	0.000604	0.0127	CbGeAlD
Tretinoin—RXRG—central nervous system—amyotrophic lateral sclerosis	0.000604	0.0127	CbGeAlD
Tretinoin—ALDH1A1—nervous system—amyotrophic lateral sclerosis	0.000598	0.0126	CbGeAlD
Tretinoin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000596	0.00492	CcSEcCtD
Tretinoin—RXRB—nervous system—amyotrophic lateral sclerosis	0.00059	0.0124	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—amyotrophic lateral sclerosis	0.000576	0.0121	CbGeAlD
Tretinoin—RXRB—central nervous system—amyotrophic lateral sclerosis	0.000568	0.012	CbGeAlD
Tretinoin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000567	0.00468	CcSEcCtD
Tretinoin—ALDH1A1—cerebellum—amyotrophic lateral sclerosis	0.000563	0.0119	CbGeAlD
Tretinoin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000558	0.0046	CcSEcCtD
Tretinoin—RXRB—cerebellum—amyotrophic lateral sclerosis	0.000555	0.0117	CbGeAlD
Tretinoin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00457	CcSEcCtD
Tretinoin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00457	CcSEcCtD
Tretinoin—CRABP2—brain—amyotrophic lateral sclerosis	0.000549	0.0116	CbGeAlD
Tretinoin—RXRA—brain—amyotrophic lateral sclerosis	0.000547	0.0115	CbGeAlD
Tretinoin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00448	CcSEcCtD
Tretinoin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000531	0.00438	CcSEcCtD
Tretinoin—RARG—nervous system—amyotrophic lateral sclerosis	0.000524	0.011	CbGeAlD
Tretinoin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00427	CcSEcCtD
Tretinoin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00427	CcSEcCtD
Tretinoin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000512	0.00422	CcSEcCtD
Tretinoin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000506	0.00417	CcSEcCtD
Tretinoin—RARG—central nervous system—amyotrophic lateral sclerosis	0.000504	0.0106	CbGeAlD
Tretinoin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000504	0.00416	CcSEcCtD
Tretinoin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000501	0.00413	CcSEcCtD
Tretinoin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000497	0.0041	CcSEcCtD
Tretinoin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000494	0.00407	CcSEcCtD
Tretinoin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000494	0.00407	CcSEcCtD
Tretinoin—RARG—cerebellum—amyotrophic lateral sclerosis	0.000493	0.0104	CbGeAlD
Tretinoin—RARA—nervous system—amyotrophic lateral sclerosis	0.000493	0.0104	CbGeAlD
Tretinoin—Depression—Riluzole—amyotrophic lateral sclerosis	0.000492	0.00406	CcSEcCtD
Tretinoin—RARB—brain—amyotrophic lateral sclerosis	0.000491	0.0103	CbGeAlD
Tretinoin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00402	CcSEcCtD
Tretinoin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00399	CcSEcCtD
Tretinoin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00399	CcSEcCtD
Tretinoin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000481	0.00397	CcSEcCtD
Tretinoin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00396	CcSEcCtD
Tretinoin—RXRG—brain—amyotrophic lateral sclerosis	0.00048	0.0101	CbGeAlD
Tretinoin—RARA—central nervous system—amyotrophic lateral sclerosis	0.000474	0.00999	CbGeAlD
Tretinoin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000473	0.0039	CcSEcCtD
Tretinoin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00388	CcSEcCtD
Tretinoin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00384	CcSEcCtD
Tretinoin—RARA—cerebellum—amyotrophic lateral sclerosis	0.000464	0.00976	CbGeAlD
Tretinoin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00382	CcSEcCtD
Tretinoin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000461	0.0038	CcSEcCtD
Tretinoin—ALDH1A1—brain—amyotrophic lateral sclerosis	0.000457	0.00963	CbGeAlD
Tretinoin—RXRB—brain—amyotrophic lateral sclerosis	0.000451	0.0095	CbGeAlD
Tretinoin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00367	CcSEcCtD
Tretinoin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00366	CcSEcCtD
Tretinoin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00366	CcSEcCtD
Tretinoin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00364	CcSEcCtD
Tretinoin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00364	CcSEcCtD
Tretinoin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00044	0.00363	CcSEcCtD
Tretinoin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000438	0.00361	CcSEcCtD
Tretinoin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000437	0.0036	CcSEcCtD
Tretinoin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000435	0.00358	CcSEcCtD
Tretinoin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000419	0.00346	CcSEcCtD
Tretinoin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00342	CcSEcCtD
Tretinoin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00332	CcSEcCtD
Tretinoin—RARG—brain—amyotrophic lateral sclerosis	0.0004	0.00843	CbGeAlD
Tretinoin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000398	0.00328	CcSEcCtD
Tretinoin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000396	0.00327	CcSEcCtD
Tretinoin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00323	CcSEcCtD
Tretinoin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000388	0.0032	CcSEcCtD
Tretinoin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00318	CcSEcCtD
Tretinoin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00038	0.00314	CcSEcCtD
Tretinoin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000379	0.00312	CcSEcCtD
Tretinoin—RARA—brain—amyotrophic lateral sclerosis	0.000377	0.00793	CbGeAlD
Tretinoin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00309	CcSEcCtD
Tretinoin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00308	CcSEcCtD
Tretinoin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000362	0.00298	CcSEcCtD
Tretinoin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000358	0.00295	CcSEcCtD
Tretinoin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00294	CcSEcCtD
Tretinoin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00293	CcSEcCtD
Tretinoin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00287	CcSEcCtD
Tretinoin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00285	CcSEcCtD
Tretinoin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000341	0.00281	CcSEcCtD
Tretinoin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000339	0.0028	CcSEcCtD
Tretinoin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000337	0.00278	CcSEcCtD
Tretinoin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00276	CcSEcCtD
Tretinoin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00275	CcSEcCtD
Tretinoin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00271	CcSEcCtD
Tretinoin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00271	CcSEcCtD
Tretinoin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00271	CcSEcCtD
Tretinoin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000327	0.0027	CcSEcCtD
Tretinoin—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000327	0.00689	CbGeAlD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000326	0.00269	CcSEcCtD
Tretinoin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000325	0.00268	CcSEcCtD
Tretinoin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000321	0.00265	CcSEcCtD
Tretinoin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000318	0.00262	CcSEcCtD
Tretinoin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000315	0.0026	CcSEcCtD
Tretinoin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000315	0.0026	CcSEcCtD
Tretinoin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00258	CcSEcCtD
Tretinoin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00256	CcSEcCtD
Tretinoin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00255	CcSEcCtD
Tretinoin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00254	CcSEcCtD
Tretinoin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00254	CcSEcCtD
Tretinoin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00252	CcSEcCtD
Tretinoin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00251	CcSEcCtD
Tretinoin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00248	CcSEcCtD
Tretinoin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00243	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00237	CcSEcCtD
Tretinoin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00235	CcSEcCtD
Tretinoin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000283	0.00233	CcSEcCtD
Tretinoin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000281	0.00232	CcSEcCtD
Tretinoin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00231	CcSEcCtD
Tretinoin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000277	0.00229	CcSEcCtD
Tretinoin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00226	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00224	CcSEcCtD
Tretinoin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00224	CcSEcCtD
Tretinoin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00222	CcSEcCtD
Tretinoin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00222	CcSEcCtD
Tretinoin—CYP2A6—brain—amyotrophic lateral sclerosis	0.000266	0.0056	CbGeAlD
Tretinoin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00026	0.00214	CcSEcCtD
Tretinoin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000258	0.00212	CcSEcCtD
Tretinoin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00025	0.00206	CcSEcCtD
Tretinoin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000249	0.00205	CcSEcCtD
Tretinoin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000249	0.00205	CcSEcCtD
Tretinoin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00191	CcSEcCtD
Tretinoin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000226	0.00186	CcSEcCtD
Tretinoin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000223	0.00184	CcSEcCtD
Tretinoin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000216	0.00178	CcSEcCtD
Tretinoin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00172	CcSEcCtD
Tretinoin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0002	0.00165	CcSEcCtD
Tretinoin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000199	0.00164	CcSEcCtD
Tretinoin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000198	0.00164	CcSEcCtD
Tretinoin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000197	0.00163	CcSEcCtD
Tretinoin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000187	0.00154	CcSEcCtD
Tretinoin—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.00018	0.00379	CbGeAlD
Tretinoin—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000175	0.00369	CbGeAlD
Tretinoin—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000173	0.00365	CbGeAlD
Tretinoin—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000169	0.00355	CbGeAlD
Tretinoin—CYP2C8—brain—amyotrophic lateral sclerosis	0.000149	0.00314	CbGeAlD
Tretinoin—CYP1A1—brain—amyotrophic lateral sclerosis	0.000138	0.0029	CbGeAlD
Tretinoin—CYP2B6—brain—amyotrophic lateral sclerosis	0.000134	0.00282	CbGeAlD
Tretinoin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000132	0.00278	CbGeAlD
Tretinoin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000127	0.00268	CbGeAlD
Tretinoin—RXRB—Gene Expression—RARA—amyotrophic lateral sclerosis	6.29e-05	0.000792	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	6.24e-05	0.000785	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	6.19e-05	0.00078	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TPK1—amyotrophic lateral sclerosis	6.11e-05	0.00077	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—VAPB—amyotrophic lateral sclerosis	6.11e-05	0.00077	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.07e-05	0.000764	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.07e-05	0.000764	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.03e-05	0.00076	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.97e-05	0.000751	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.83e-05	0.000735	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	5.78e-05	0.000729	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	5.77e-05	0.000726	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.7e-05	0.000718	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	5.6e-05	0.000706	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.6e-05	0.000705	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—VAPA—amyotrophic lateral sclerosis	5.59e-05	0.000704	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.45e-05	0.000686	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.37e-05	0.000676	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	5.35e-05	0.000674	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—VAPB—amyotrophic lateral sclerosis	5.34e-05	0.000673	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TPK1—amyotrophic lateral sclerosis	5.34e-05	0.000673	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.28e-05	0.000665	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.2e-05	0.000655	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.06e-05	0.000637	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.99e-05	0.000629	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.98e-05	0.000628	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	4.95e-05	0.000623	CbGpPWpGaD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	4.91e-05	0.000618	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—FIG4—amyotrophic lateral sclerosis	4.89e-05	0.000616	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—VAPA—amyotrophic lateral sclerosis	4.89e-05	0.000616	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	4.85e-05	0.000611	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	4.85e-05	0.000611	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	4.84e-05	0.00061	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.75e-05	0.000599	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.71e-05	0.000593	CbGpPWpGaD
Tretinoin—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.64e-05	0.000584	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.63e-05	0.000583	CbGpPWpGaD
Tretinoin—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.57e-05	0.000576	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.57e-05	0.000575	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.56e-05	0.000574	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.54e-05	0.000572	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.52e-05	0.000569	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	4.43e-05	0.000559	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—DAO—amyotrophic lateral sclerosis	4.42e-05	0.000557	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000555	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.35e-05	0.000549	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	4.32e-05	0.000544	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.3e-05	0.000541	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.3e-05	0.000541	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—FIG4—amyotrophic lateral sclerosis	4.27e-05	0.000538	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.25e-05	0.000535	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.25e-05	0.000535	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.16e-05	0.000524	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.16e-05	0.000524	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.12e-05	0.000519	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.06e-05	0.000512	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.04e-05	0.000509	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	4.02e-05	0.000506	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.99e-05	0.000503	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	3.89e-05	0.00049	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	3.88e-05	0.000488	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	3.86e-05	0.000487	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.83e-05	0.000483	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.72e-05	0.000468	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.71e-05	0.000467	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.64e-05	0.000458	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.59e-05	0.000452	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00045	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00045	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00045	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	3.55e-05	0.000447	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	3.55e-05	0.000447	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	3.51e-05	0.000442	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.48e-05	0.000439	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.46e-05	0.000435	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.44e-05	0.000434	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.43e-05	0.000432	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.38e-05	0.000426	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.35e-05	0.000422	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PLB1—amyotrophic lateral sclerosis	3.35e-05	0.000422	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.31e-05	0.000416	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.29e-05	0.000414	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.28e-05	0.000414	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.28e-05	0.000414	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.28e-05	0.000414	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	3.28e-05	0.000413	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.26e-05	0.00041	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.26e-05	0.00041	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.25e-05	0.000409	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	3.25e-05	0.000409	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.17e-05	0.000399	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.12e-05	0.000393	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSR—amyotrophic lateral sclerosis	3.09e-05	0.000389	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.02e-05	0.00038	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.01e-05	0.00038	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.98e-05	0.000376	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.98e-05	0.000375	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	2.93e-05	0.000369	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.9e-05	0.000366	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.86e-05	0.000361	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	2.84e-05	0.000358	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.82e-05	0.000355	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.8e-05	0.000352	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.77e-05	0.000349	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.74e-05	0.000345	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	0.00034	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	0.00034	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	0.00034	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	2.7e-05	0.00034	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	2.66e-05	0.000335	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.63e-05	0.000331	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.63e-05	0.000331	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.6e-05	0.000328	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	2.57e-05	0.000324	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.57e-05	0.000323	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.57e-05	0.000323	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.00032	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	2.45e-05	0.000309	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.000306	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.000306	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.4e-05	0.000303	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.37e-05	0.000299	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000298	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.35e-05	0.000297	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.35e-05	0.000296	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.000293	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.32e-05	0.000292	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.26e-05	0.000285	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.23e-05	0.000281	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.23e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.22e-05	0.00028	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.22e-05	0.00028	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000279	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.22e-05	0.000279	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.18e-05	0.000275	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.1e-05	0.000265	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.07e-05	0.000261	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.06e-05	0.00026	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.05e-05	0.000259	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.03e-05	0.000256	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	2.01e-05	0.000254	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	1.95e-05	0.000245	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.94e-05	0.000244	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.9e-05	0.000239	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.89e-05	0.000238	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.86e-05	0.000234	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.000233	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.000233	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.000233	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.84e-05	0.000231	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.81e-05	0.000228	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.81e-05	0.000228	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.8e-05	0.000226	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.79e-05	0.000226	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.78e-05	0.000225	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.78e-05	0.000224	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.75e-05	0.000221	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.69e-05	0.000213	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.66e-05	0.000209	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.65e-05	0.000207	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.61e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.59e-05	0.0002	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.56e-05	0.000196	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.54e-05	0.000194	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.54e-05	0.000194	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.48e-05	0.000186	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.45e-05	0.000182	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.44e-05	0.000181	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.41e-05	0.000177	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.36e-05	0.000172	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.35e-05	0.00017	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.000167	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.33e-05	0.000167	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.31e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.3e-05	0.000164	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.26e-05	0.000159	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000158	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.24e-05	0.000156	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.000155	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.22e-05	0.000154	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.19e-05	0.00015	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.19e-05	0.00015	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.00015	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.12e-05	0.000142	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000141	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.11e-05	0.00014	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000138	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.09e-05	0.000138	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.09e-05	0.000137	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-05	0.000136	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.000134	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000129	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.02e-05	0.000128	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000127	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.94e-06	0.000125	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	9.92e-06	0.000125	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.54e-06	0.00012	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	9.24e-06	0.000116	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.19e-06	0.000116	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	9.15e-06	0.000115	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	9.02e-06	0.000114	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.63e-06	0.000109	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.43e-06	0.000106	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.34e-06	0.000105	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	8.18e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.93e-06	9.99e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.52e-06	9.47e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.29e-06	9.18e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.27e-06	9.15e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.07e-06	8.9e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.86e-06	8.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.68e-06	8.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.54e-06	8.24e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.3e-06	7.93e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.18e-06	7.78e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.04e-06	7.6e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	5.99e-06	7.55e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.86e-06	7.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.77e-06	7.27e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.73e-06	7.22e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.61e-06	7.06e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	5.49e-06	6.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.41e-06	6.82e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.39e-06	6.79e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.27e-06	6.63e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.98e-06	6.27e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.96e-06	6.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.96e-06	6.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.7e-06	5.92e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.56e-06	5.75e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	4.43e-06	5.58e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.33e-06	5.46e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.11e-06	5.17e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.09e-06	5.16e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.04e-06	5.09e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.76e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.75e-06	4.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.71e-06	4.68e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.05e-06	3.85e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.04e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.97e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	3.53e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.66e-06	3.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.57e-06	3.24e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.45e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.09e-06	2.64e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.01e-06	2.54e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.38e-06	1.74e-05	CbGpPWpGaD
